VIENNA, Austria — Compared with subcutaneous interferon β-1a (IFNB-1a; Rebif/EMD Serono/Pfizer), treatment with alemtuzumab (Lemtrada, Genzyme/Sanofi) improved visual outcomes in treatment-naive ...
A simple technique to measure an individual's visual processing speed -- the speed at which an individual can comprehend visual information -- has been developed in order to identify whether or not ...
Online eyewear and vision care company Visibly announced it had received FDA 510(k) clearance for its at-home vision test. The Visibly Digital Acuity Product uses a touchscreen mobile device, like a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback